See What HealthDay Can Do For You
Contact Us

Overall Vagotomy Not Linked to Risk of Parkinson's Disease

But there is a trend toward lower risk of Parkinson's for patients with truncal vagotomy

brain model

THURSDAY, April 27, 2017 (HealthDay News) -- Overall vagotomy is not associated with the risk of Parkinson's disease (PD), according to a study published online April 26 in Neurology.

Bojing Liu, from the Karolinska Institutet in Sweden, and colleagues conducted a matched-cohort study of 9,430 vagotomized patients (3,445 truncal and 5,978 selective) identified between 1970 and 2010 and 377,200 reference individuals matched by sex and year of birth in a 40-to-1 ratio. They followed participants from the date of vagotomy until PD diagnosis, death, or emigration or until Dec. 31, 2010.

During 7.3 million person-years of follow-up, the researchers identified 4,930 cases of incident PD. The incidence of PD was 61.8 and 67.5 per 100,000 person-years among vagotomized patients and reference individuals, respectively. Overall, there was no correlation for vagotomy with the risk of PD (hazard ratio, 0.96; 95 percent confidence interval, 0.78 to 1.17). Patients with truncal vagotomy had a trend toward lower risk (hazard ratio, 0.78; 95 percent confidence interval, 0.55 to 1.09), which may have been driven by truncal vagotomy at least five years before diagnosis (hazard ratio, 0.59; 95 percent confidence interval, 0.37 to 0.93). There was no correlation between selective vagotomy and the risk of PD.

"Although overall vagotomy was not associated [with] the risk of PD, we found suggestive evidence for a potential protective effect of truncal, but not selective, vagotomy against PD development," the authors write.

Full Text

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.